Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recombinant Mouse Tumor Necrosis Factor Ligand Superfamily Member 13 (TNFSF13), N-Fc

Cat. No.AP2C904

Product TypeAnimal Proteins

Size

Product Overview

BioVenic's Recombinant Mouse Tumor Necrosis Factor Ligand Superfamily Member 13 (TNFSF13), N-Fc is a recombinant protein expressed from Human Cells. Its predicted molecular weight is 26.9 kDa. The purity is>90%.

Specifications

Type Recombinant Protein
Species Mouse
Expression System Human Cells
Purity >90%
Endotoxin < 1.0 EU/μg
Predicted Molecular Weight 26.9 kDa
Physical State Lyophilized
Formulation 0.01 mol/L PBS (pH 7.2) containing 0.2% (w/v) Procline-300.

Target Information

Mouse Tumor Necrosis Factor Ligand Superfamily Member 13 (TNFSF13) is involved in immune responses. It plays a role in B cell activation, influencing antibody production and immune defense. TNFSF13 has been implicated in autoimmune diseases, where abnormal B cell activation leads to autoantibody production. In cancer, TNFSF13 may influence tumor-immune interactions. This protein is a potential target for therapeutic intervention in autoimmune diseases and cancer.

Protein Mouse Tumor Necrosis Factor Ligand Superfamily Member 13 (TNFSF13)
Protein Synonym A proliferation-inducing ligand; APRIL
Gene ID 69583
UniProt ID Q9D777

Shipping and Storage

This product is shipped with ice packs. Lyophilized protein can be stored at -20°C for 1 year. After reconstitution, the protein solution can be stored at 2-8°C for 2-7 days.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

User Note

  1. Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquot the reconstituted solution to minimize freeze-thaw cycles.
Inquiry Basket